Učitavanje...
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome
RAS is an oncogene frequently mutated in human cancer. RAS mutations have been reported in 10–15% of cases of acute myeloid leukemia (AML) but they appear to be less frequent among patients with myelodys-plastic syndrome (MDS). The impact of RAS mutations in patients with MDS is unclear. We conducte...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4089101/ https://ncbi.nlm.nih.gov/pubmed/23512829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23410 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|